Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tectonic Therapeutic, Inc.

25.63
+2.129.02%
Post-market: 25.630.00000.00%17:59 EDT
Volume:140.33K
Turnover:3.51M
Market Cap:472.67M
PE:-7.07
High:25.75
Open:23.76
Low:23.76
Close:23.51
Loading ...

Tectonic Therapeutic Announces Positive Interim Data From Phase 1B Trial for Tx45 in Patients With Group 2 Pulmonary Hypertension in Hfpef

THOMSON REUTERS
·
30 Jan

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

GlobeNewswire
·
30 Jan

Tectonic Therapeutic Down Over 36%, on Pace for Largest Percent Decrease Since January 2022 -- Data Talk

Dow Jones
·
29 Jan

Tectonic Therapeutic Inc trading resumes

TIPRANKS
·
29 Jan

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

GlobeNewswire
·
04 Dec 2024

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

GlobeNewswire
·
27 Nov 2024

Raymond James Initiates Tectonic Therapeutic at Outperform

MT Newswires Live
·
20 Nov 2024

Tectonic Therapeutic Inc : Raymond James Initiates Coverage With Outperform Rating; Target Price $65

THOMSON REUTERS
·
20 Nov 2024

Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks

TIPRANKS
·
14 Nov 2024

Tectonic Therapeutic Inc. Reports Q3 2024 Results

TipRanks
·
13 Nov 2024

Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain

Simply Wall St.
·
12 Nov 2024

Tectonic Therapeutic Is Maintained at Outperform by Leerink Partners

Dow Jones
·
12 Nov 2024

Tectonic Therapeutic price target raised to $69 from $49 at Leerink

TIPRANKS
·
12 Nov 2024

Leerink Partners Raises Tectonic Therapeutic's Price Target to $69 From $49, Outperform Rating Maintained

MT Newswires Live
·
12 Nov 2024

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

GlobeNewswire
·
11 Nov 2024

Stock Track | Tectonic Therapeutic Stock Plummets 5.4% After Wider Q3 Loss Miss

Stock Track
·
08 Nov 2024